title: Screening strategy for type 2 diabetes in the United Arab Emirates.
abstract: The prevalence of type 2 diabetes mellitus (DM) among Emirati nationals is one of the highest in the world. The recently released United Arab Emirates National DM guidelines call for screening all adults aged 30 years and more. The authors explored the need for such a modification of current American Diabetes Association (ADA) guidelines. They also considered the prevalence rates for undiagnosed DM based on oral glucose tolerance test (OGTT) versus glycohemoglobin (HbA( 1c)) >or= 6.5% in a population-based sample of 296 adult Emirati participants. In the low-risk ADA category, defined by age <45 years and BMI <25, only 1 of 68 (1.5%) participants was diagnosed with DM. The overall rate of DM based on HbA(1c) was lower than that based on OGTT (10.1% versus 14.2%; P < .05). The authors conclude that the ADA guidelines are adequate for screening in this high-risk population. They also find high discordance between HbA(1c) and OGTT.
authors.affiliation: Department of Internal Medicine, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. saadih@uaeu.ac.ae
authors.forename: Hussein
authors.initials: H
authors.lastname: Saadi
authors.forename: Nicolaas
authors.initials: N
authors.lastname: Nagelkerke
authors.forename: Jumaa
authors.initials: J
authors.lastname: Al-Kaabi
authors.forename: Bachar
authors.initials: B
authors.lastname: Afandi
authors.forename: Fatima
authors.initials: F
authors.lastname: Al-Maskari
authors.forename: Elsadig
authors.initials: E
authors.lastname: Kazam
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000453:epidemiology; D005951:Glucose Tolerance Test / Q000706:statistics & numerical data; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D017410:Practice Guidelines as Topic / Q000592:standards*; D015995:Prevalence; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014479:United Arab Emirates / Q000453:epidemiology; D014481:United States; D014837:Voluntary Health Agencies
chemical_list: D006442:Glycated Hemoglobin